| (USD) | Jun 2023 | Q/Q |
|---|---|---|
| Revenue | 13.8MM | +6% |
| Gross Profit | 7.8MM | +5% |
| Cost Of Revenue | 6MM | +8% |
| Operating Income | -4.9MM | -31% |
| Operating Expenses | 12.7MM | -12% |
| Net Income | -4.2MM | -35% |
| G&A | 12.2MM | -13% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Freshpet, OptimizeRx and Pinterest have been highlighted in this Screen of The Week article.
OptimizeRx Corp. (OPRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The mean of analysts' price targets for OptimizeRx Corp. (OPRX) points to a 47.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
OptimizeRx Corporation ( NASDAQ:OPRX ) shareholders will have a reason to smile today, with the analysts making...
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2023 Earnings Call Transcript November 6, 2023 Operator: Good morning, everyone and thank you for joining OptimizeRx’s Third Quarter Fiscal 2023 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by company Chief Financial Officer, Ed Stelmakh; President Steve Silvestro; General Counsel Marion […]
Q3 2023 OPTIMIZERx Corp Earnings Call
Total revenue of $16.3 million, GAAP net loss per share of $(0.17), Non-GAAP net income per share of $0.09
- Increases guidance for 2023 and introduces guidance for 2024- Total revenue of $16.3 million- GAAP net loss per share of $(0.17)- Non-GAAP net income per share of $0.09- Total DAAP (fka RWD) deals for the year now stands at 16- Completed acquisition of Medicx Health after quarter end WALTHAM, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcar
OptimizeRx Corporation ( NASDAQ:OPRX ) shareholders should be happy to see the share price up 17% in the last month...
OptimizeRx Corp. (OPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.